PROTHENA CORPORATION PUBLIC LIMITED COMPANY Other Non-Current Liabilities
PROTHENA CORPORATION PUBLIC LIMITED COMPANY (PRTA) had Other Non-Current Liabilities of $0 as of 2023-12-31, per its 10-K filed 2024-02-22.
Discontinued › Balance Sheet › Liabilities › Liabilities, Other than Long-Term Debt, Noncurrent
us-gaap:OtherLiabilitiesNoncurrent · last filed 2024-02-22
- 2023-12-31: Other Liabilities, Noncurrent $0.00.
- 2023-09-30: Other Liabilities, Noncurrent $0.00.
- 2023-06-30: Other Liabilities, Noncurrent $0.00.
- 2023-03-31: Other Liabilities, Noncurrent $0.00.
| Period end | Other Liabilities, Noncurrent |
|---|---|
| 2023-12-31 | $0.00 10-K · filed 2024-02-22 |
| 2023-09-30 | $0.00 10-Q · filed 2023-11-02 |
| 2023-06-30 | $0.00 10-Q · filed 2023-08-03 |
| 2023-03-31 | $0.00 10-Q · filed 2023-05-04 |
| 2022-12-31 | $553.00K 10-K · filed 2024-02-22 |
| 2022-09-30 | $553.00K 10-Q · filed 2022-11-03 |
| 2022-06-30 | $553.00K 10-Q · filed 2022-08-08 |
| 2022-03-31 | $553.00K 10-Q · filed 2022-05-05 |
| 2021-12-31 | $553.00K 10-K · filed 2023-02-28 |
| 2021-09-30 | $553.00K 10-Q · filed 2021-11-04 |
| 2021-06-30 | $553.00K 10-Q · filed 2021-08-05 |
| 2021-03-31 | $553.00K 10-Q · filed 2021-05-11 |
| 2020-12-31 | $553.00K 10-K · filed 2022-02-25 |
| 2020-09-30 | $553.00K 10-Q · filed 2020-11-04 |
| 2020-06-30 | $553.00K 10-Q · filed 2020-08-06 |
| 2020-03-31 | $553.00K 10-Q · filed 2020-05-06 |
| 2019-12-31 | $553.00K 10-K · filed 2021-02-26 |
| 2019-09-30 | $553.00K 10-Q · filed 2019-11-05 |
| 2019-06-30 | $553.00K 10-Q · filed 2019-08-06 |
| 2019-03-31 | $553.00K 10-Q · filed 2019-05-07 |
| 2018-12-31 | $553.00K 10-K · filed 2020-03-03 |
| 2018-09-30 | $553.00K 10-Q · filed 2018-11-06 |
| 2017-12-31 | $0.00 10-K · filed 2019-03-15 |
| 2016-12-31 | $0.00 10-K · filed 2017-02-27 |
| 2016-09-30 | $0.00 10-Q · filed 2016-11-02 |
| 2016-06-30 | $126.00K 10-Q · filed 2016-08-02 |
| 2016-03-31 | $126.00K 10-Q · filed 2016-05-04 |
| 2015-12-31 | $126.00K 10-K · filed 2017-02-27 |
| 2015-09-30 | $126.00K 10-Q · filed 2015-11-02 |
| 2015-06-30 | $126.00K 10-Q · filed 2015-08-05 |
| 2015-03-31 | $126.00K 10-Q · filed 2015-05-06 |
| 2014-12-31 | $0.00 10-K · filed 2016-02-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| DiaMedica Therapeutics Inc. (DMAC) | United States | $0.423B | -10.11 |
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |
| Atea Pharmaceuticals, Inc. (AVIR) | United States | $0.414B | -2.26 |
| ARS Pharmaceuticals, Inc. (SPRY) | United States | $0.414B | -3.70 |
| Quoin Pharmaceuticals Ltd. (QNRX) | $0.443B | -17.85 | |
| RELMADA THERAPEUTICS, INC. (RLMD) | United States | $0.406B | -11.92 |
| Opus Genetics, Inc. (IRD) | United States | $0.406B | -3.16 |
| Arcturus Therapeutics Holdings Inc. (ARCT) | $0.402B | -2.05 | |
| GALECTIN THERAPEUTICS INC (GALT) | United States | $0.399B | -11.06 |
| MapLight Therapeutics, Inc. (MPLT) | United States | $0.459B | -7.10 |